About
Co-founder of the o2h Group and a life sciences entrepreneur who previously co-founded Oxygen Healthcare (acquired by Piramal). A UKBAA Angel Investor of the Year (2019), he serves as chair, director, or investor across 20+ UK biotech companies and holds a biochemistry degree from Keele and an MBA from Cambridge.
Experience
- o2h groupCEO, o2h Ventures | Co-founder @ o2h Groupcurrent2003 — presentGreater Cambridge Area
- BioIndustry AssociationBoard Membercurrent2020 — presentLondon Area, United Kingdom
- EXONATE LIMITEDMember Board of Directorscurrent2015 — presentGreater Cambridge Area
- KuanoMember Board of Directorscurrent2021 — presentCambridge, England, United Kingdom
- Alevin Therapeutics LtdExecutive Chairmancurrent2022 — presentCambridgeshire, England, United Kingdom
- Oxford Drug DesignBoard Membercurrent2017 — presentGreater Oxford Area
- Cambridge Judge Business SchoolAssociatecurrent2020 — presentUnited Kingdom
- Metrion BiosciencesBoard Observercurrent2019 — presentGreater Cambridge Area
- OPPILOTECH LTDBoard Observercurrent2017 — presentLondon Area, United Kingdom
- Cambridge AngelsBoard Member2018 — 2025Greater Cambridge Area
- Opal Therapeutics LimitedChairman Of The Board2013 — 2022Greater Cambridge Area
- India-UK Cancer Research Initiative (CRUK-DBT)Advisory Panel Member2019 — 2021London Area, United Kingdom
- Oxygen Healthcare Ltd (Later: Piramal Enterprises)CEO and Co-Founder2003 — 2013Greater Cambridge Area
- Gosurprise LtdCEO2000 — 2003Greater Cambridge Area
- PA ConsultingConsultant1994 — 1998Greater Cambridge Area
Education
- University of CambridgeMBA, Business1998 — 1999
- Keele UniversityBSc, Biochemistry and Management Sciences1991 — 1994
Skills & more
Board LevelDrug Discovery99Technology Transfer50Biotechnology91R&D25Lifesciences46Chemistry13Organic Chemistry7Commercialization19Pharmacology5Patents1Pharmaceutics2
+12 more
Drug DevelopmentBiopharmaceuticalsIntellectual PropertyMedicinal ChemistryInfectious DiseasesCancerEntrepreneurshipProtein ChemistryStrategyPharmaceutical IndustryCROBiochemistryFrom Sunil's professional profile.
Colleagues at O2h Ventures
Ajit Singh Guller
Marketing Manager at O2h Ventures
Andy Morley
Principal at O2h Ventures
Catherine Beech
Independent Representative to the Investment Advisory Panel at O2h Ventures
Catherine Stace
VP - Strategic Relationships at O2h Ventures
Cengiz Tarhan
Independent Representative of the Investment Advisory Panel at O2h Ventures
Chris Reid
Venture Partner at O2h Ventures
Chris White
Vice President, Business Development at O2h Ventures
Dr Chris Torrance
Independent Representative of the Investment Advisory Panel at O2h Ventures
Frequently asked questions
- Where does Sunil Shah work?
- Sunil Shah is CEO at O2h Ventures.
Same school
Also attended University of Cambridge851
Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesLeah von SiemensPartner at Manta Ray VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)
.png)
+ 845 more
Also attended Keele University12
Joanna LeeInvestment Associate at Giant LeapJoshua GoldInvestor at TMV LogisticsCeri BaileyHead of Fund Coordination & Client Reporting at Mercia VenturesDale AldersonPartner, Head of North West at LDCEmily HaniotisPrincipal, Investments at DiagramMunder ShuhumiFounder / Managing Partner at Pearls Capital
.jpg)
+ 6 more
Shared employers
Also worked at o2h group7
Andy MorleyPrincipal at O2h VenturesNilesh DagiaVenture Partner at O2h VenturesCatherine StaceVP - Strategic Relationships at O2h VenturesGayathri SadasivamVP - Scientific Due Diligence at O2h VenturesRiddhi AhujaSenior Fund Operations Manager at O2h VenturesAjit Singh GullerMarketing Manager at O2h Ventures
+ 1 more
.webp)